Home » Topics » BioWorld Science

BioWorld Science
RSS

Promising preliminary phase II results for argatroban in acute MI

Oct. 25, 1996

Anti-TNF MAb effective in treating septic shock in two major studies

Oct. 25, 1996

Progress on Neuprex for hemorrhagic trauma

Oct. 25, 1996

cGMP PDE inhibitors reported by DuPont Merck

Oct. 25, 1996

AM-140 available for licensing

Oct. 25, 1996

Antiarrhythmic compounds described by SKB

Oct. 25, 1996

PLC Systems' Heart Laser superior to holmium and excimer lasers for TMR

Oct. 25, 1996

GV-1201/GV-1202 available for licensing

Oct. 25, 1996

Gensia turns over development of Geomatrix nifedipine product

Oct. 25, 1996

Phase IV study results reported for ramipril

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...